Search Results 3521-3530 of 26499 for oral

1. Hematology - Clinical trials

   ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

2. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

   ... (oral vs rectal vs both oral and rectal); (3) role of oral budesonide in patients mild-moderate UC; (4) comparative effectiveness and tolerability of rectal ...

3. Publications - Steven Attia, D.O. - Mayo Clinic

   Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma. Ann Oncol. 2018 ...

4. Publications - John V. Murray, Jr., M.D. - Mayo Clinic

   Oral Maxillofac Surg Clin North Am. 2023 Aug; 35 (3):451-468 Epub 2023 Apr 07. View PubMed; Beegle RD, Murray JV Jr, Sandhu SJS. Normal and Variant Sinonasal ...

5. Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS) - Mayo Clinic

   ... oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner for the duration of study participation and an additional ...

6. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   ... oral calcineurin inhibitors; high potency or oral steroids). History of idiopathic pulmonary fibrosis, pneumonitis (including drug induced), organizing ...

7. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection - Mayo Clinic

   ... oral antibiotic therapy; or; has had at least two episodes of severe CDI resulting in hospitalization. A positive stool test for the presence of toxigenic C ...

8. A Study of Macitentan in Pulmonary Hypertension After Left Ventricular Assist Device Implantation - Mayo Clinic

   ... oral prostanoids, or guanylate cyclase stimulators within 7 days prior to baseline RHC, or planned treatment during the study period; Treatment with inhaled ...

9. Ryan J. Solinsky, M.D. - Doctors and Medical Staff - Mayo Clinic

   Best Oral Presentation AwardInternational Autonomic Symposium, Vancouver, BC, CAN. 2017. Post-doctoral Fellow- Best Research AwardKessler Institute for ...

10. EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway - Mayo Clinic

    ... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) ...